Quince eyes PhIII start for rare pediatric disease drug-device as FDA lifts hold
29 Sep 2023 //
ENDPTS
FDA Partial Hold Lifted on IND for EryDel’s Lead Phase 3 Asset EryDex
28 Sep 2023 //
BUSINESSWIRE
29 Sep 2023 //
ENDPTS
28 Sep 2023 //
BUSINESSWIRE